21/120
0.9 / 5 stars
All 120 Win/Lose results shown below
BAX Roast Me summary
BAXTER INTERNATIONAL INC (BAX). Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
- 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
Trailing 1 year (4 quarters): 1 wins, 11 lossesLast fetched: 25 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
WinBAX / S&P 26.97% / 15.20% |
LoseBAX / S&P BAX unavailable / 15.00% |
LoseBAX / S&P BAX unavailable / 50.40% |
| 2026-Q10/3 |
LoseBAX / S&P -12.04% / -4.33% |
LoseBAX / S&P BAX unavailable / 11.30% |
LoseBAX / S&P BAX unavailable / 27.70% |
| 2025-Q40/3 |
LoseBAX / S&P -16.03% / 2.65% |
LoseBAX / S&P BAX unavailable / 9.00% |
LoseBAX / S&P BAX unavailable / 13.40% |
| 2025-Q30/3 |
LoseBAX / S&P -24.27% / 8.12% |
LoseBAX / S&P BAX unavailable / 4.61% |
LoseBAX / S&P -430.00% / 13.45% |
| 2025-Q20/3 |
LoseBAX / S&P -11.05% / 10.94% |
LoseBAX / S&P BAX unavailable / 4.83% |
LoseBAX / S&P -106.17% / 10.63% |
| 2025-Q11/3 |
WinBAX / S&P 17.96% / -4.27% |
LoseBAX / S&P BAX unavailable / 4.98% |
LoseBAX / S&P -121.00% / 10.57% |
| 2024-Q40/3 |
LoseBAX / S&P -22.81% / 2.41% |
LoseBAX / S&P BAX unavailable / 5.25% |
LoseBAX / S&P -124.28% / 6.15% |
| 2024-Q31/3 |
WinBAX / S&P 14.38% / 5.89% |
LoseBAX / S&P BAX unavailable / 5.89% |
LoseBAX / S&P -96.09% / 6.11% |
| 2024-Q20/3 |
LoseBAX / S&P -21.05% / 4.28% |
LoseBAX / S&P BAX unavailable / 5.38% |
LoseBAX / S&P BAX unavailable / 5.12% |
| 2024-Q11/3 |
WinBAX / S&P 11.33% / 10.56% |
LoseBAX / S&P BAX unavailable / 5.71% |
LoseBAX / S&P BAX unavailable / 5.59% |
| 2023-Q40/3 |
LoseBAX / S&P 3.26% / 11.69% |
LoseBAX / S&P BAX unavailable / 6.81% |
LoseBAX / S&P BAX unavailable / 7.78% |
| 2023-Q30/3 |
LoseBAX / S&P -16.59% / -3.27% |
LoseBAX / S&P BAX unavailable / 7.52% |
LoseBAX / S&P BAX unavailable / -5.03% |
| 2023-Q21/3 |
WinBAX / S&P 13.13% / 8.74% |
LoseBAX / S&P BAX unavailable / 9.50% |
LoseBAX / S&P -382.50% / -8.57% |
| 2023-Q10/3 |
LoseBAX / S&P -19.86% / 7.50% |
LoseBAX / S&P BAX unavailable / 10.77% |
LoseBAX / S&P -333.01% / -15.69% |
| 2022-Q40/3 |
LoseBAX / S&P -4.88% / 7.56% |
LoseBAX / S&P BAX unavailable / 11.88% |
LoseBAX / S&P -290.91% / -17.99% |
| 2022-Q30/3 |
LoseBAX / S&P -15.72% / -4.88% |
LoseBAX / S&P BAX unavailable / 13.47% |
LoseBAX / S&P -298.32% / -1.41% |
| 2022-Q20/3 |
LoseBAX / S&P -16.84% / -16.10% |
LoseBAX / S&P BAX unavailable / 13.71% |
LoseBAX / S&P -8.26% / 11.04% |
| 2022-Q10/3 |
LoseBAX / S&P -9.37% / -4.60% |
LoseBAX / S&P BAX unavailable / 15.97% |
LoseBAX / S&P 0.97% / 42.23% |
| 2021-Q40/3 |
LoseBAX / S&P 7.13% / 11.03% |
LoseBAX / S&P BAX unavailable / 15.00% |
LoseBAX / S&P 18.78% / 96.40% |
| 2021-Q30/3 |
LoseBAX / S&P 0.27% / 0.58% |
LoseBAX / S&P BAX unavailable / 10.77% |
LoseBAX / S&P 34.46% / 69.42% |
| 2021-Q20/3 |
LoseBAX / S&P -4.22% / 8.55% |
LoseBAX / S&P BAX unavailable / 6.58% |
LoseBAX / S&P 21.79% / 51.81% |
| 2021-Q11/3 |
LoseBAX / S&P 5.44% / 6.17% |
LoseBAX / S&P BAX unavailable / -1.06% |
WinBAX / S&P 8.38% / 7.39% |
| 2020-Q41/3 |
LoseBAX / S&P 0.10% / 12.15% |
LoseBAX / S&P BAX unavailable / -3.72% |
WinBAX / S&P 10.36% / -33.42% |
| 2020-Q30/3 |
LoseBAX / S&P -6.33% / 8.93% |
LoseBAX / S&P BAX unavailable / -2.04% |
LoseBAX / S&P -30.31% / -27.10% |
| 2020-Q20/3 |
LoseBAX / S&P 6.34% / 20.54% |
LoseBAX / S&P BAX unavailable / -0.46% |
LoseBAX / S&P -35.61% / -27.11% |
| 2020-Q11/3 |
WinBAX / S&P -2.66% / -19.60% |
LoseBAX / S&P BAX unavailable / 3.47% |
LoseBAX / S&P -32.03% / -14.75% |
| 2019-Q40/3 |
LoseBAX / S&P -4.15% / 9.07% |
LoseBAX / S&P BAX unavailable / 5.36% |
LoseBAX / S&P -31.80% / 2.99% |
| 2019-Q32/3 |
WinBAX / S&P 7.07% / 1.70% |
LoseBAX / S&P BAX unavailable / 5.02% |
WinBAX / S&P 30.26% / 0.21% |
| 2019-Q21/3 |
LoseBAX / S&P 1.01% / 4.30% |
LoseBAX / S&P BAX unavailable / 6.64% |
WinBAX / S&P 91.72% / 8.65% |
| 2019-Q12/3 |
WinBAX / S&P 23.85% / 13.65% |
LoseBAX / S&P BAX unavailable / 8.12% |
WinBAX / S&P 116.15% / 14.29% |
| 2018-Q41/3 |
LoseBAX / S&P -14.38% / -13.52% |
LoseBAX / S&P BAX unavailable / 9.05% |
WinBAX / S&P 162.04% / 18.23% |
| 2018-Q30/3 |
LoseBAX / S&P 4.67% / 7.71% |
LoseBAX / S&P BAX unavailable / 10.21% |
LoseBAX / S&P 3.72% / 19.06% |
| 2018-Q21/3 |
WinBAX / S&P 13.83% / 3.43% |
LoseBAX / S&P BAX unavailable / 9.03% |
LoseBAX / S&P -13.17% / 14.46% |
| 2018-Q11/3 |
WinBAX / S&P 0.86% / -0.76% |
LoseBAX / S&P 4.87% / 7.68% |
LoseBAX / S&P -61.54% / 12.46% |
| 2017-Q40/3 |
LoseBAX / S&P 3.27% / 6.64% |
LoseBAX / S&P 3.92% / 7.03% |
LoseBAX / S&P -88.01% / 13.82% |
| 2017-Q30/3 |
LoseBAX / S&P 3.92% / 4.48% |
LoseBAX / S&P 3.07% / 5.68% |
LoseBAX / S&P -78.92% / 17.57% |
| 2017-Q21/3 |
WinBAX / S&P 17.05% / 3.09% |
LoseBAX / S&P 2.32% / 4.83% |
LoseBAX / S&P -80.76% / 17.74% |
| 2017-Q11/3 |
WinBAX / S&P 17.26% / 6.07% |
LoseBAX / S&P 3.25% / 3.67% |
LoseBAX / S&P -52.33% / 13.32% |
| 2016-Q41/3 |
LoseBAX / S&P -6.58% / 3.82% |
LoseBAX / S&P 1.96% / 2.09% |
WinBAX / S&P 411.93% / 7.05% |
| 2016-Q32/3 |
WinBAX / S&P 5.56% / 3.85% |
LoseBAX / S&P -0.32% / 0.20% |
WinBAX / S&P 185.90% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | BAX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 6.02% | 20.78% |
| Annualized return | 6.02% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | BAX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -62.73% | 83.14% |
| Annualized return | -17.91% | 12.86% |
10Y · 2016-09-01 to 2026-08-28
| Metric | BAX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -34.02% | 319.30% |
| Annualized return | -4.07% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-25.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |